(+)-schisandrin B multiple interactions ISO RGD:1308982 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of PRKDC mRNA] CTD PMID:31150632 (-)-alpha-phellandrene decreases expression EXP 6480464 alpha phellandrene results in decreased expression of PRKDC protein CTD PMID:24861204 (-)-demecolcine decreases expression ISO RGD:1319072 6480464 Demecolcine results in decreased expression of PRKDC mRNA CTD PMID:23649840 1,2-dimethylhydrazine increases expression EXP 6480464 1, 2-Dimethylhydrazine results in increased expression of PRKDC mRNA CTD PMID:22206623 1-chloro-2,4-dinitrobenzene affects binding ISO RGD:1319072 6480464 Dinitrochlorobenzene binds to PRKDC protein CTD PMID:32991956 1-nitropyrene increases expression ISO RGD:1319072 6480464 1-nitropyrene results in increased expression of PRKDC protein CTD PMID:28633978 17beta-estradiol decreases expression ISO RGD:1319072 6480464 Estradiol results in decreased expression of PRKDC mRNA CTD PMID:15223131 17beta-estradiol increases expression ISO RGD:1319072 6480464 Estradiol results in increased expression of PRKDC mRNA CTD PMID:16514628 more ... 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:1319072 6480464 2 more ... CTD PMID:22233939 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:1319072 6480464 2 more ... CTD PMID:31675489 2,2',4,4'-Tetrabromodiphenyl ether affects response to substance ISO RGD:1319072 6480464 PRKDC protein affects the susceptibility to 2 more ... CTD PMID:22233939 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1308982 6480464 Tetrachlorodibenzodioxin results in decreased expression of PRKDC mRNA CTD PMID:32109520 , PMID:33387578 2,3,7,8-Tetrachlorodibenzofuran decreases expression ISO RGD:1308982 6480464 2 more ... CTD PMID:32109520 2,4,6-tribromophenol decreases expression ISO RGD:1319072 6480464 2 more ... CTD PMID:31675489 3,3',5,5'-tetrabromobisphenol A decreases expression ISO RGD:1319072 6480464 tetrabromobisphenol A results in decreased expression of PRKDC protein CTD PMID:31675489 3-aminobenzamide multiple interactions ISO RGD:1319072 6480464 3-aminobenzamide inhibits the reaction [Capsaicin results in increased phosphorylation of and results in increased activity of PRKDC protein] CTD PMID:22226932 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1319072 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of PRKDC mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of PRKDC mRNA CTD PMID:28628672 3-Nitrofluoranthene increases expression ISO RGD:1319072 6480464 3-nitrofluoranthene results in increased expression of PRKDC protein CTD PMID:28633978 4,4'-sulfonyldiphenol affects methylation EXP 6480464 bis(4-hydroxyphenyl)sulfone affects the methylation of PRKDC gene CTD PMID:31683443 4,4'-sulfonyldiphenol increases expression ISO RGD:1319072 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of PRKDC protein CTD PMID:34186270 4-amino-1,8-naphthalimide affects response to substance EXP 6480464 PRKDC protein affects the susceptibility to 4-amino-1, 8-naphthalimide CTD PMID:16556909 4-amino-1,8-naphthalimide multiple interactions EXP 6480464 PRKDC protein affects the reaction [4-amino-1, 8-naphthalimide results in decreased activity of PARP1 protein] CTD PMID:16556909 4-hydroxynon-2-enal decreases expression ISO RGD:1319072 6480464 4-hydroxy-2-nonenal results in decreased expression of PRKDC mRNA CTD PMID:12419474 4-nitrophenol increases expression EXP 6480464 4-nitrophenol results in increased expression of PRKDC mRNA CTD PMID:34673133 5-aza-2'-deoxycytidine affects methylation ISO RGD:1319072 6480464 Decitabine affects the methylation of PRKDC gene CTD PMID:17630775 5-fluorouracil multiple interactions ISO RGD:1319072 6480464 PRKDC mRNA results in increased susceptibility to [Fluorouracil co-treated with Cisplatin], TP53 protein affects the reaction [Fluorouracil results in decreased expression of PRKDC mRNA] CTD PMID:15016801 , PMID:18546291 7,12-dimethyltetraphene decreases expression EXP 6480464 9 more ... CTD PMID:25448685 7,12-dimethyltetraphene multiple interactions EXP 6480464 9 more ... CTD PMID:25448685 7,12-dimethyltetraphene increases expression EXP 6480464 9 more ... CTD PMID:25448685 acrolein multiple interactions ISO RGD:1319072 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PRKDC mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of PRKDC mRNA CTD PMID:32699268 afimoxifene decreases expression ISO RGD:1319072 6480464 afimoxifene results in decreased expression of PRKDC mRNA CTD PMID:16514628 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of PRKDC mRNA CTD PMID:19770486 Aflatoxin B2 alpha affects methylation ISO RGD:1319072 6480464 aflatoxin B2 affects the methylation of PRKDC intron CTD PMID:30157460 all-trans-retinoic acid decreases expression ISO RGD:1319072 6480464 Tretinoin results in decreased expression of PRKDC mRNA CTD PMID:15498508 , PMID:33167477 alpha-phellandrene decreases expression EXP 6480464 alpha phellandrene results in decreased expression of PRKDC protein CTD PMID:24861204 alpha-pinene multiple interactions ISO RGD:1319072 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PRKDC mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of PRKDC mRNA CTD PMID:32699268 amphetamine decreases expression ISO RGD:1308982 6480464 Amphetamine results in decreased expression of PRKDC mRNA CTD PMID:30779732 aphidicolin multiple interactions ISO RGD:1319072 6480464 Caffeine promotes the reaction [Aphidicolin promotes the reaction [PRKDC protein results in increased phosphorylation of and results in increased activity of CHEK2 protein]] CTD PMID:18158334 arecoline decreases expression ISO RGD:1319072 6480464 Arecoline results in decreased expression of PRKDC mRNA CTD PMID:17682004 aristolochic acid A decreases expression ISO RGD:1319072 6480464 aristolochic acid I results in decreased expression of PRKDC mRNA CTD PMID:33212167 arsane increases response to substance ISO RGD:1319072 6480464 PRKDC mRNA results in increased susceptibility to Arsenic CTD PMID:17976673 arsane increases expression ISO RGD:1319072 6480464 Arsenic results in increased expression of PRKDC protein CTD PMID:19818359 arsane decreases expression ISO RGD:1319072 6480464 Arsenic results in decreased expression of PRKDC mRNA, Arsenic results in decreased expression of PRKDC protein CTD PMID:21332098 arsane multiple interactions ISO RGD:1319072 6480464 Curcumin inhibits the reaction [Arsenic results in decreased expression of PRKDC mRNA], Curcumin inhibits the reaction [Arsenic results in decreased expression of PRKDC protein] CTD PMID:21332098 arsenic atom decreases expression ISO RGD:1319072 6480464 Arsenic results in decreased expression of PRKDC mRNA, Arsenic results in decreased expression of PRKDC protein CTD PMID:21332098 arsenic atom increases expression ISO RGD:1319072 6480464 Arsenic results in increased expression of PRKDC protein CTD PMID:19818359 arsenic atom increases response to substance ISO RGD:1319072 6480464 PRKDC mRNA results in increased susceptibility to Arsenic CTD PMID:17976673 arsenic atom multiple interactions ISO RGD:1319072 6480464 Curcumin inhibits the reaction [Arsenic results in decreased expression of PRKDC mRNA], Curcumin inhibits the reaction [Arsenic results in decreased expression of PRKDC protein] CTD PMID:21332098 arsenite(3-) increases activity ISO RGD:1319072 6480464 arsenite results in increased activity of PRKDC protein CTD PMID:22366412 arsenite(3-) multiple interactions ISO RGD:1319072 6480464 [[[arsenite results in increased activity of PRKDC protein] which results in increased phosphorylation of and results in increased activity of MAPK9 protein] promotes the reaction [MAPK9 protein binds to TP53 protein]] inhibits the reaction [MDM2 results in increased degradation of and results in decreased stability of TP53 protein] more ... CTD PMID:22366412 , PMID:32406909 atrazine decreases expression ISO RGD:1319072 6480464 Atrazine results in decreased expression of PRKDC mRNA CTD PMID:22378314 benzene increases expression ISO RGD:1319072 6480464 Benzene results in increased expression of PRKDC mRNA CTD PMID:20036648 benzene increases expression EXP 6480464 Benzene metabolite results in increased expression of PRKDC mRNA CTD PMID:23940708 benzene affects expression ISO RGD:1319072 6480464 Benzene affects the expression of PRKDC mRNA CTD PMID:16188086 benzo[a]pyrene decreases methylation ISO RGD:1319072 6480464 Benzo(a)pyrene results in decreased methylation of PRKDC 3' UTR CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:1319072 6480464 Benzo(a)pyrene affects the methylation of PRKDC intron CTD PMID:30157460 benzo[a]pyrene decreases expression ISO RGD:1319072 6480464 Benzo(a)pyrene results in decreased expression of PRKDC mRNA CTD PMID:20064835 more ... benzo[a]pyrene multiple interactions EXP 6480464 PRKDC protein affects the susceptibility to [Caffeine co-treated with Benzo(a)pyrene], PRKDC protein affects the susceptibility to [wortmannin co-treated with Benzo(a)pyrene] CTD PMID:20888899 benzo[e]pyrene decreases methylation ISO RGD:1319072 6480464 benzo(e)pyrene results in decreased methylation of PRKDC intron CTD PMID:30157460 biphenyl-4-amine multiple interactions ISO RGD:1319072 6480464 TP53 protein inhibits the reaction [4-biphenylamine results in decreased expression of PRKDC mRNA] CTD PMID:32905825 biphenyl-4-amine decreases expression ISO RGD:1319072 6480464 4-biphenylamine results in decreased expression of PRKDC mRNA CTD PMID:32905825 bisphenol A increases expression ISO RGD:1319072 6480464 bisphenol A results in increased expression of PRKDC mRNA, bisphenol A results in increased expression of PRKDC protein CTD PMID:15223131 , PMID:34186270 bisphenol A decreases expression ISO RGD:1308982 6480464 bisphenol A results in decreased expression of PRKDC mRNA CTD PMID:30816183 bisphenol A increases expression ISO RGD:1308982 6480464 bisphenol A results in increased expression of PRKDC mRNA CTD PMID:27208089 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of PRKDC mRNA CTD PMID:26063408 , PMID:33221593 bisphenol A multiple interactions ISO RGD:1319072 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of PRKDC mRNA more ... CTD PMID:23227178 , PMID:28628672 bisphenol A affects binding ISO RGD:1319072 6480464 bisphenol A binds to PRKDC protein CTD PMID:23227178 Bisphenol B increases expression ISO RGD:1319072 6480464 bisphenol B results in increased expression of PRKDC protein CTD PMID:34186270 bisphenol F multiple interactions ISO RGD:1319072 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of PRKDC mRNA CTD PMID:28628672 bortezomib decreases expression ISO RGD:1319072 6480464 Bortezomib results in decreased expression of PRKDC mRNA CTD PMID:20977926 bortezomib multiple interactions ISO RGD:1319072 6480464 [CASP8 protein results in increased activity of CASP3 protein] affects the reaction [Bortezomib results in increased cleavage of PRKDC protein], benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [Bortezomib results in increased cleavage of PRKDC protein] CTD PMID:12393500 bortezomib increases cleavage ISO RGD:1319072 6480464 Bortezomib results in increased cleavage of PRKDC protein CTD PMID:12393500 bromoacetate increases expression ISO RGD:1319072 6480464 bromoacetate results in increased expression of PRKDC mRNA CTD PMID:19753638 butanal decreases expression ISO RGD:1319072 6480464 butyraldehyde results in decreased expression of PRKDC mRNA CTD PMID:26079696 caffeine multiple interactions ISO RGD:1319072 6480464 Caffeine promotes the reaction [Aphidicolin promotes the reaction [PRKDC protein results in increased phosphorylation of and results in increased activity of CHEK2 protein]] CTD PMID:18158334 caffeine affects phosphorylation ISO RGD:1319072 6480464 Caffeine affects the phosphorylation of PRKDC protein CTD PMID:35688186 caffeine multiple interactions EXP 6480464 PRKDC protein affects the susceptibility to [Caffeine co-treated with Benzo(a)pyrene] CTD PMID:20888899 capsaicin increases phosphorylation ISO RGD:1319072 6480464 Capsaicin results in increased phosphorylation of PRKDC protein CTD PMID:22226932 capsaicin multiple interactions ISO RGD:1319072 6480464 3-aminobenzamide inhibits the reaction [Capsaicin results in increased phosphorylation of and results in increased activity of PRKDC protein] more ... CTD PMID:22226932 casticin decreases expression ISO RGD:1319072 6480464 casticin results in decreased expression of PRKDC protein CTD PMID:29098808 chromium atom increases activity ISO RGD:1319072 6480464 Chromium results in increased activity of PRKDC protein CTD PMID:18602874 chromium atom multiple interactions ISO RGD:1319072 6480464 PRKDC protein promotes the reaction [Chromium results in increased stability of and results in increased activity of TP53 protein] CTD PMID:18602874 cisplatin multiple interactions EXP 6480464 Cisplatin promotes the reaction [PRKDC protein binds to EGFR protein] more ... CTD PMID:21266349 , PMID:21324906 cisplatin increases expression ISO RGD:1319072 6480464 Cisplatin results in increased expression of PRKDC mRNA CTD PMID:25450742 cisplatin increases response to substance EXP 6480464 PRKDC protein mutant form results in increased susceptibility to Cisplatin CTD PMID:21324906 cisplatin multiple interactions ISO RGD:1319072 6480464 [Cisplatin results in decreased susceptibility to Cisplatin] which results in increased expression of PRKDC mRNA, PRKDC mRNA results in increased susceptibility to [Fluorouracil co-treated with Cisplatin] CTD PMID:18546291 , PMID:30871063 clofibrate multiple interactions EXP 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of PRKDC mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of PRKDC mRNA] CTD PMID:17585979 cobalt dichloride decreases expression ISO RGD:1319072 6480464 cobaltous chloride results in decreased expression of PRKDC mRNA CTD PMID:19320972 , PMID:19376846 copper atom multiple interactions ISO RGD:1319072 6480464 [Chelating Agents binds to Copper] which results in decreased expression of PRKDC mRNA CTD PMID:30911355 copper(0) multiple interactions ISO RGD:1319072 6480464 [Chelating Agents binds to Copper] which results in decreased expression of PRKDC mRNA CTD PMID:30911355 coumarin increases phosphorylation ISO RGD:1319072 6480464 coumarin results in increased phosphorylation of PRKDC protein CTD PMID:35688186 coumestrol multiple interactions ISO RGD:1319072 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PRKDC mRNA CTD PMID:19167446 coumestrol increases expression ISO RGD:1319072 6480464 Coumestrol results in increased expression of PRKDC mRNA CTD PMID:19167446 curcumin multiple interactions ISO RGD:1319072 6480464 Curcumin inhibits the reaction [Arsenic results in decreased expression of PRKDC mRNA], Curcumin inhibits the reaction [Arsenic results in decreased expression of PRKDC protein] CTD PMID:21332098 curcumin decreases expression ISO RGD:1319072 6480464 Curcumin results in decreased expression of PRKDC mRNA CTD PMID:17596214 deguelin decreases expression ISO RGD:1319072 6480464 deguelin results in decreased expression of PRKDC mRNA CTD PMID:22227970 dexamethasone multiple interactions ISO RGD:1319072 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of PRKDC mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of PRKDC mRNA CTD PMID:28628672 dibutyl phthalate increases expression ISO RGD:1308982 6480464 Dibutyl Phthalate results in increased expression of PRKDC mRNA CTD PMID:21266533 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of PRKDC mRNA CTD PMID:17361019 , PMID:21266533 dichlorvos increases expression ISO RGD:1308982 6480464 Dichlorvos results in increased expression of PRKDC mRNA, Dichlorvos results in increased expression of PRKDC protein CTD PMID:24369695 dichlorvos multiple interactions ISO RGD:1308982 6480464 TEMPOL-H inhibits the reaction [Dichlorvos results in increased expression of PRKDC mRNA] CTD PMID:24369695 dicrotophos increases expression ISO RGD:1319072 6480464 dicrotophos results in increased expression of PRKDC mRNA CTD PMID:28302478 dioxygen multiple interactions EXP 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PRKDC mRNA CTD PMID:30529165 doxorubicin multiple interactions ISO RGD:1319072 6480464 Doxorubicin promotes the reaction [PRKDC protein results in increased phosphorylation of PRKDC protein] more ... CTD PMID:18508926 , PMID:21567185 doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of PRKDC mRNA CTD PMID:25896364 endosulfan decreases expression ISO RGD:1308982 6480464 Endosulfan results in decreased expression of PRKDC mRNA CTD PMID:29391264 Enterolactone multiple interactions ISO RGD:1319072 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PRKDC mRNA CTD PMID:19167446 enzyme inhibitor multiple interactions ISO RGD:1319072 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of PRKDC protein CTD PMID:23301498 etoposide increases phosphorylation ISO RGD:1319072 6480464 Etoposide results in increased phosphorylation of PRKDC protein CTD PMID:17441964 etoposide multiple interactions ISO RGD:1319072 6480464 PRKDC protein promotes the reaction [Etoposide results in increased phosphorylation of SP1 protein] CTD PMID:17441964 folic acid affects expression ISO RGD:1319072 6480464 Folic Acid affects the expression of PRKDC mRNA CTD PMID:16361273 folic acid decreases expression EXP 6480464 Folic Acid results in decreased expression of PRKDC mRNA CTD PMID:25629700 fulvestrant decreases expression ISO RGD:1319072 6480464 fulvestrant results in decreased expression of PRKDC mRNA CTD PMID:16514628 furan decreases expression ISO RGD:1308982 6480464 furan results in decreased expression of PRKDC mRNA CTD PMID:22507866 gallic acid decreases expression ISO RGD:1319072 6480464 Gallic Acid results in decreased expression of PRKDC mRNA CTD PMID:21887735 glyphosate decreases expression ISO RGD:1319072 6480464 glyphosate results in decreased expression of PRKDC mRNA CTD PMID:31295307 hydrogen peroxide affects expression ISO RGD:1319072 6480464 Hydrogen Peroxide affects the expression of PRKDC mRNA CTD PMID:21179406 hydroquinone increases expression ISO RGD:1319072 6480464 hydroquinone results in increased expression of PRKDC mRNA, hydroquinone results in increased expression of PRKDC protein CTD PMID:20036648 hydroquinone increases expression EXP 6480464 hydroquinone results in increased expression of PRKDC mRNA CTD PMID:23940708 indometacin multiple interactions ISO RGD:1319072 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of PRKDC mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of PRKDC mRNA CTD PMID:28628672 irinotecan increases phosphorylation ISO RGD:1319072 6480464 Irinotecan results in increased phosphorylation of PRKDC protein CTD PMID:17441964 , PMID:21221710 irinotecan multiple interactions ISO RGD:1319072 6480464 IC486241 inhibits the reaction [Irinotecan results in increased phosphorylation of PRKDC protein] CTD PMID:21221710 ivermectin decreases expression ISO RGD:1319072 6480464 Ivermectin results in decreased expression of PRKDC protein CTD PMID:32959892 josamycin affects response to substance ISO RGD:1319072 6480464 PRKDC protein affects the susceptibility to Josamycin CTD PMID:31915244 lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of PRKDC mRNA CTD PMID:20542052 lycopene decreases expression ISO RGD:1319072 6480464 lycopene results in decreased expression of PRKDC mRNA CTD PMID:16886892 methapyrilene decreases methylation ISO RGD:1319072 6480464 Methapyrilene results in decreased methylation of PRKDC intron CTD PMID:30157460 monocrotaline multiple interactions EXP 6480464 [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC gene mutant form] results in increased expression of MKI67 protein more ... CTD PMID:21224054 motexafin gadolinium increases expression ISO RGD:1319072 6480464 motexafin gadolinium results in increased expression of PRKDC mRNA CTD PMID:16357179 myristicin decreases expression ISO RGD:1319072 6480464 myristicin results in decreased expression of PRKDC mRNA CTD PMID:24792648 N-acetyl-L-cysteine increases expression ISO RGD:1319072 6480464 Acetylcysteine results in increased expression of PRKDC protein CTD PMID:31715134 N-acetyl-L-cysteine multiple interactions ISO RGD:1319072 6480464 Acetylcysteine inhibits the reaction [usnic acid results in increased expression of PRKDC protein] CTD PMID:31715134 nickel atom increases expression ISO RGD:1319072 6480464 Nickel results in increased expression of PRKDC mRNA CTD PMID:24768652 , PMID:25583101 nickel dichloride affects expression ISO RGD:1308982 6480464 nickel chloride affects the expression of PRKDC mRNA CTD PMID:22546817 nickel dichloride increases expression ISO RGD:1319072 6480464 nickel chloride results in increased expression of PRKDC protein CTD PMID:28472268 ochratoxin A increases expression ISO RGD:1308982 6480464 ochratoxin A results in increased expression of PRKDC mRNA CTD PMID:23358140 ouabain decreases expression ISO RGD:1319072 6480464 Ouabain results in decreased expression of PRKDC protein CTD PMID:31436044 oxaliplatin multiple interactions ISO RGD:1308982 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of PRKDC mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:1319072 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PRKDC mRNA more ... CTD PMID:32699268 paracetamol multiple interactions EXP 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of PRKDC mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of PRKDC mRNA] CTD PMID:17585979 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of PRKDC mRNA CTD PMID:29540258 paracetamol decreases expression ISO RGD:1319072 6480464 Acetaminophen results in decreased expression of PRKDC mRNA CTD PMID:21420995 phenol increases expression ISO RGD:1319072 6480464 Phenol results in increased expression of PRKDC more ... CTD PMID:20036648 , PMID:20096274 phenol affects localization ISO RGD:1319072 6480464 Phenol affects the localization of PRKDC protein CTD PMID:20096274 phenytoin multiple interactions EXP 6480464 [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC gene mutant form] results in increased expression of MKI67 protein more ... CTD PMID:21224054 phosphoramide mustard affects expression ISO RGD:1308982 6480464 phosphoramide mustard affects the expression of PRKDC mRNA, phosphoramide mustard affects the expression of PRKDC protein CTD PMID:25497287 phosphoramide mustard increases expression ISO RGD:1308982 6480464 phosphoramide mustard results in increased expression of PRKDC mRNA CTD PMID:26708502 pirinixic acid multiple interactions EXP 6480464 [pirinixic acid co-treated with PPARA] results in increased expression of PRKDC mRNA, PPARA protein promotes the reaction [pirinixic acid results in increased expression of PRKDC mRNA] CTD PMID:17950772 more ... pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of PRKDC mRNA CTD PMID:17950772 more ... quercetin decreases expression ISO RGD:1319072 6480464 Quercetin results in decreased expression of PRKDC mRNA CTD PMID:20596804 quercetin decreases expression EXP 6480464 Quercetin results in decreased expression of PRKDC mRNA CTD PMID:25862958 raloxifene decreases expression ISO RGD:1319072 6480464 Raloxifene Hydrochloride results in decreased expression of PRKDC mRNA CTD PMID:16514628 resveratrol decreases expression ISO RGD:1308982 6480464 Resveratrol results in decreased expression of PRKDC mRNA CTD PMID:33775663 resveratrol multiple interactions ISO RGD:1319072 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of PRKDC mRNA CTD PMID:23557933 rifampicin multiple interactions EXP 6480464 [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC gene mutant form] results in increased expression of MKI67 protein more ... CTD PMID:21224054 serpentine asbestos multiple interactions EXP 6480464 PRKDC affects the reaction [Asbestos more ... CTD PMID:16571779 , PMID:17200189 sodium arsenite increases expression ISO RGD:1319072 6480464 sodium arsenite results in increased expression of PRKDC mRNA CTD PMID:28595984 tamibarotene decreases expression ISO RGD:1319072 6480464 tamibarotene results in decreased expression of PRKDC mRNA CTD PMID:15498508 tamibarotene affects expression ISO RGD:1319072 6480464 tamibarotene affects the expression of PRKDC mRNA CTD PMID:15498508 tetrachloromethane multiple interactions ISO RGD:1308982 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of PRKDC mRNA] CTD PMID:31150632 tetrachloromethane decreases expression ISO RGD:1308982 6480464 Carbon Tetrachloride results in decreased expression of PRKDC mRNA CTD PMID:31150632 thioacetamide decreases expression ISO RGD:1308982 6480464 Thioacetamide results in decreased expression of PRKDC mRNA CTD PMID:34492290 topotecan decreases expression ISO RGD:1308982 6480464 Topotecan results in decreased expression of PRKDC mRNA CTD PMID:25729387 topotecan multiple interactions ISO RGD:1308982 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of PRKDC mRNA CTD PMID:25729387 trichloroethene decreases expression ISO RGD:1308982 6480464 Trichloroethylene results in decreased expression of PRKDC mRNA CTD PMID:33387578 trichostatin A increases expression ISO RGD:1319072 6480464 trichostatin A results in increased expression of PRKDC mRNA CTD PMID:24935251 trovafloxacin decreases expression EXP 6480464 trovafloxacin results in decreased expression of PRKDC mRNA CTD PMID:35537566 tungsten decreases expression EXP 6480464 Tungsten results in decreased expression of PRKDC mRNA CTD PMID:30912803 urethane decreases expression ISO RGD:1319072 6480464 Urethane results in decreased expression of PRKDC mRNA CTD PMID:28818685 usnic acid increases expression ISO RGD:1319072 6480464 usnic acid results in increased expression of PRKDC protein CTD PMID:31715134 usnic acid multiple interactions ISO RGD:1319072 6480464 Acetylcysteine inhibits the reaction [usnic acid results in increased expression of PRKDC protein] CTD PMID:31715134 valproic acid affects expression ISO RGD:1319072 6480464 Valproic Acid affects the expression of PRKDC mRNA CTD PMID:25979313 valproic acid increases expression ISO RGD:1319072 6480464 Valproic Acid results in increased expression of PRKDC mRNA CTD PMID:29154799 vinclozolin increases expression ISO RGD:1308982 6480464 vinclozolin results in increased expression of PRKDC mRNA CTD PMID:23034163 , PMID:23555832 vincristine increases expression ISO RGD:1319072 6480464 Vincristine results in increased expression of PRKDC mRNA CTD PMID:23649840 vorinostat decreases expression ISO RGD:1319072 6480464 vorinostat results in decreased expression of PRKDC protein CTD PMID:20531243 wortmannin multiple interactions EXP 6480464 PRKDC protein affects the susceptibility to [wortmannin co-treated with Benzo(a)pyrene] CTD PMID:20888899 zinc acetate increases expression ISO RGD:1319072 6480464 Zinc Acetate results in increased expression of PRKDC mRNA CTD PMID:16357179